US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
CA1288073C
(en)
|
1985-03-07 |
1991-08-27 |
Paul G. Ahlquist |
Rna transformation vector
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
US5968509A
(en)
|
1990-10-05 |
1999-10-19 |
Btp International Limited |
Antibodies with binding affinity for the CD3 antigen
|
DK0590058T3
(da)
|
1991-06-14 |
2004-03-29 |
Genentech Inc |
Humaniseret heregulin-antistof
|
GB9206422D0
(en)
|
1992-03-24 |
1992-05-06 |
Bolt Sarah L |
Antibody preparation
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
CA2249195A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
AU751659B2
(en)
|
1997-05-02 |
2002-08-22 |
Genentech Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
EP1141274B2
(en)
|
1999-01-07 |
2014-11-12 |
ZymoGenetics, Inc. |
Soluble receptor br43x2 and methods of using them for therapy
|
EP1210425B2
(en)
|
1999-08-17 |
2015-06-17 |
Biogen MA Inc. |
Baff receptor (bcma), an immunoregulatory agent
|
AU6232899A
(en)
|
1999-10-06 |
2001-05-10 |
Campina Melkunie B.V. |
Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
|
UA74798C2
(uk)
|
1999-10-06 |
2006-02-15 |
Байоджен Айдек Ма Інк. |
Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами
|
EP1272647B1
(en)
|
2000-04-11 |
2014-11-12 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
ATE361318T1
(de)
|
2000-05-12 |
2007-05-15 |
Amgen Inc |
Polypeptiden, die die april-vermittelte aktivierung von t-und b-zellen hemmen
|
EP2301971A1
(en)
|
2001-02-20 |
2011-03-30 |
ZymoGenetics, L.L.C. |
Antibodies that bind both BCMA and TACI
|
CN1195779C
(zh)
|
2001-05-24 |
2005-04-06 |
中国科学院遗传与发育生物学研究所 |
抗人卵巢癌抗人cd3双特异性抗体
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
AU2003287345A1
(en)
|
2002-10-31 |
2004-06-07 |
Genentech, Inc. |
Methods and compositions for increasing antibody production
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
EP1629012B1
(en)
|
2003-05-31 |
2018-11-28 |
Amgen Research (Munich) GmbH |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
|
CA2522894C
(en)
|
2003-05-31 |
2013-06-25 |
Micromet Ag |
Pharmaceutical composition comprising a bispecific antibody specific for epcam
|
WO2005040220A1
(en)
|
2003-10-16 |
2005-05-06 |
Micromet Ag |
Multispecific deimmunized cd3-binders
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
BRPI0511782B8
(pt)
|
2004-06-03 |
2021-05-25 |
Novimmune Sa |
anticorpos anti-cd3, uso e método de produção dos mesmos, composição farmacêutica, molécula de ácido nucleico isolada e vetor
|
KR101443473B1
(ko)
|
2004-07-22 |
2014-09-22 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
Vh 결합 영역의 분리 방법
|
BRPI0607203A2
(pt)
|
2005-02-18 |
2009-08-25 |
Medarex Inc |
anticorpo anti-cd30 isolado, célula hospedeira, métodos para inibir o crescimento de células cd30+, e, uso de um anticorpo anti-cd30 desfucosilado
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
US20080311078A1
(en)
|
2005-06-14 |
2008-12-18 |
Gokarn Yatin R |
Self-Buffering Protein Formulations
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
EA014025B1
(ru)
|
2005-09-12 |
2010-08-30 |
Новиммун С.А. |
Композиции антитела против cd3
|
CA2625440C
(en)
|
2005-10-11 |
2023-06-13 |
Micromet Ag |
Compositions comprising cross-species-specific antibodies and uses thereof
|
CA2629306A1
(en)
|
2005-11-23 |
2007-05-31 |
Genentech, Inc. |
Methods and compositions related to b cell assays
|
WO2007066109A1
(en)
|
2005-12-06 |
2007-06-14 |
Domantis Limited |
Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
|
WO2007117600A2
(en)
|
2006-04-07 |
2007-10-18 |
Macrogenics, Inc. |
Combination therapy for treating autoimmune diseases
|
EP2079483A4
(en)
|
2006-07-29 |
2010-10-20 |
Robert Lamar Bjork Jr |
BISPECIFIC MONOCLONAL ANTIBODIES (SPECIFIC FOR CD3 AND CD11B) THERAPEUTIC MEDICAMENTS
|
PL2155788T3
(pl)
|
2007-04-03 |
2013-02-28 |
Amgen Res Munich Gmbh |
Swoiste międzygatunkowe bispecyficzne czynniki wiążące
|
AU2008234020B2
(en)
|
2007-04-03 |
2013-02-07 |
Amgen Research (Munich) Gmbh |
Cross-species-specific CD3-epsilon binding domain
|
SI2155783T1
(sl)
|
2007-04-03 |
2013-10-30 |
Amgen Research (Munich) Gmbh |
Medvrstno specifiäśna cd3-epsilon vezavna domena
|
LT2602323T
(lt)
|
2007-06-01 |
2018-04-10 |
Open Monoclonal Technology, Inc. |
Kompozicijos ir būdai endogeninių imunoglobulinų genams slopinti ir transgeniniams žmogaus idiotipo antikūnams gaminti
|
PL2202245T3
(pl)
|
2007-09-26 |
2017-02-28 |
Chugai Seiyaku Kabushiki Kaisha |
Sposób modyfikowania punktu izoelektrycznego przeciwciała poprzez podstawienie aminokwasu w cdr
|
CN103232541A
(zh)
|
2007-10-26 |
2013-08-07 |
俄克拉荷马医学研究基金会 |
针对活化蛋白c的单克隆抗体
|
JP5739326B2
(ja)
|
2008-04-25 |
2015-06-24 |
ザイモジェネティクス, インコーポレイテッド |
B細胞上でのbcmaタンパク発現レベル及び診断法における使用
|
US20100122358A1
(en)
|
2008-06-06 |
2010-05-13 |
Crescendo Biologics Limited |
H-Chain-only antibodies
|
RS54299B1
(en)
*
|
2008-07-17 |
2016-02-29 |
Novartis Ag |
COMPOSITIONS AND METHODS OF USING THERAPY ANTIBODIES
|
PL2352763T5
(pl)
|
2008-10-01 |
2023-01-30 |
Amgen Research (Munich) Gmbh |
Bispecyficzne przeciwciała jednołańcuchowe o specyficzności wobec antygenów docelowych o dużej masie cząsteczkowej
|
CA2738545A1
(en)
|
2008-10-01 |
2010-04-08 |
Micromet Ag |
Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
|
ME02485B
(me)
|
2008-10-01 |
2017-02-20 |
Amgen Res Munich Gmbh |
Bispecifično jednolančano protutijelo psmaxcd3 s međuvrsnom specifičnošću
|
US10981998B2
(en)
|
2008-10-01 |
2021-04-20 |
Amgen Research (Munich) Gmbh |
Cross-species-specific single domain bispecific single chain antibody
|
HUE029619T4
(en)
|
2009-03-10 |
2017-07-28 |
Biogen Ma Inc |
Anti-bcma antibodies
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
US9345661B2
(en)
|
2009-07-31 |
2016-05-24 |
Genentech, Inc. |
Subcutaneous anti-HER2 antibody formulations and uses thereof
|
HUE045591T2
(hu)
|
2010-02-08 |
2019-12-30 |
Regeneron Pharma |
Közönséges könnyûláncú egér
|
TWI653333B
(zh)
|
2010-04-01 |
2019-03-11 |
安進研究(慕尼黑)有限責任公司 |
跨物種專一性之PSMAxCD3雙專一性單鏈抗體
|
EP3974453A3
(en)
|
2010-11-16 |
2022-08-03 |
Amgen Inc. |
Agents and methods for treating diseases that correlate with bcma expression
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
US20130101599A1
(en)
|
2011-04-21 |
2013-04-25 |
Boehringer Ingelheim International Gmbh |
Bcma-based stratification and therapy for multiple myeloma patients
|
UA112434C2
(uk)
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
Антигензв'язувальний білок, який специфічно зв'язується з всма
|
LT3415531T
(lt)
|
2011-05-27 |
2023-09-25 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) – surišantys baltymai
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
RU2766608C2
(ru)
|
2012-04-11 |
2022-03-15 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток
|
BR112014025830A8
(pt)
|
2012-04-20 |
2017-10-10 |
Emergent Product Dev Seattle |
Polipeptídeos de ligação ao cd3
|
WO2014022540A1
(en)
|
2012-08-02 |
2014-02-06 |
Regeneron Pharmaceuticals, Inc. |
Multivalent antigen-binding proteins
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
US10002206B2
(en)
|
2012-10-26 |
2018-06-19 |
Saturn Licensing Llc |
Information processing device and information processing method
|
WO2014068079A1
(en)
|
2012-11-01 |
2014-05-08 |
Max-Delbrück-Centrum für Molekulare Medizin |
An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
PL2931030T5
(pl)
|
2012-12-14 |
2024-06-10 |
Open Monoclonal Technology, Inc. |
Polinukleotydy kodujące przeciwciała gryzoni z ludzkimi idiotypami i zawierające je zwierzęta
|
JPWO2014112144A1
(ja)
|
2013-01-15 |
2017-01-19 |
国立大学法人 熊本大学 |
染色体セントロメア由来のサテライトノンコーディングrnaを標的とした核酸抗癌剤、及び該抗癌剤を用いる方法
|
EP2762497A1
(en)
|
2013-02-05 |
2014-08-06 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
WO2014122143A1
(en)
|
2013-02-05 |
2014-08-14 |
Engmab Ag |
Method for the selection of antibodies against bcma
|
MY172430A
(en)
|
2013-04-29 |
2019-11-25 |
Hoffmann La Roche |
Human fcrn-binding modified antibodies and methods of use
|
EP3066133A1
(en)
|
2013-11-04 |
2016-09-14 |
Glenmark Pharmaceuticals S.A. |
Production of t cell retargeting hetero-dimeric immunoglobulins
|
WO2015095412A1
(en)
|
2013-12-19 |
2015-06-25 |
Zhong Wang |
Bispecific antibody with two single-domain antigen-binding fragments
|
WO2015121383A1
(en)
|
2014-02-12 |
2015-08-20 |
Michael Uhlin |
Bispecific antibodies for use in stem cell transplantation
|
EP3811970A1
(en)
|
2014-03-15 |
2021-04-28 |
Novartis AG |
Regulatable chimeric antigen receptor
|
TWI701042B
(zh)
|
2014-03-19 |
2020-08-11 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
EA201691925A1
(ru)
|
2014-03-28 |
2017-06-30 |
Ксенкор, Инк. |
Биспецифические антитела, которые связываются с cd38 и cd3
|
BR112016028378A2
(pt)
|
2014-06-06 |
2017-10-24 |
Bristol Myers Squibb Co |
anticorpos contra o receptor do fator de necrose tumoral induzido por glicocorticoide (gitr) e usos dos mesmos
|
SG11201700476VA
(en)
|
2014-07-21 |
2017-02-27 |
Novartis Ag |
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
|
AU2015292590B2
(en)
|
2014-07-24 |
2020-01-16 |
2Seventy Bio, Inc. |
BCMA chimeric antigen receptors
|
AU2015292406B2
(en)
|
2014-07-25 |
2021-03-11 |
Cytomx Therapeutics, Inc |
Anti-CD3 antibodies, activatable anti-CD3 antibodies, multispecific anti-CD3 antibodies, multispecific activatable anti-CD3 antibodies, and methods of using the same
|
MA44560B2
(fr)
|
2014-07-31 |
2021-01-29 |
Sanofi Sa |
Anticorps anti-cd38 spécifiques pour le traitement de cancers humains
|
EP2990416B1
(en)
|
2014-08-29 |
2018-06-20 |
GEMoaB Monoclonals GmbH |
Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders
|
AP2017009823A0
(en)
|
2014-09-26 |
2017-03-31 |
Macrogenics Inc |
Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
|
CN105457024B
(zh)
|
2014-10-13 |
2021-03-16 |
李小彦 |
抗butyrophilin-3人源化抗体及其使用
|
DK3209698T4
(da)
|
2014-10-22 |
2022-04-04 |
Crescendo Biologics Ltd |
Transgene mus
|
EP3023437A1
(en)
|
2014-11-20 |
2016-05-25 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
MX2017006626A
(es)
|
2014-11-20 |
2017-08-21 |
Hoffmann La Roche |
Cadenas ligeras comunes y metodos de uso.
|
NZ733025A
(en)
|
2014-12-12 |
2022-01-28 |
2Seventy Bio Inc |
Bcma chimeric antigen receptors
|
GB201500461D0
(en)
*
|
2015-01-12 |
2015-02-25 |
Cresendo Biolog Ltd |
Therapeutic molecules
|
CR20170526A
(es)
|
2015-05-20 |
2018-04-03 |
Janssen Biotech Inc |
ANTICUERPOS ANTI-CD38 PARA EL TRATAMIENTO DE AMILOIDOSIS DE CADENA LIGERA y OTRAS ENFERMEDADES MALIGNAS HEMATOLÓGICAS POSITIVAS PARA CD38
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
DK3337824T3
(da)
*
|
2015-08-17 |
2020-08-24 |
Janssen Pharmaceutica Nv |
Anti-bcma-antistoffer, bispecifikke antigen-bindende molekyler, som binder bcma og cd3, og anvendelse deraf
|
CN108884162A
(zh)
|
2015-11-10 |
2018-11-23 |
汉堡-埃普多夫大学医学中心 |
针对cd38的抗原结合多肽
|
JP7432363B2
(ja)
*
|
2016-06-21 |
2024-02-16 |
テネオバイオ, インコーポレイテッド |
Cd3結合抗体
|
KR20230039773A
(ko)
*
|
2016-08-24 |
2023-03-21 |
테네오바이오, 인코포레이티드 |
변형된 중쇄-단독 항체를 생산하는 형질전환 비-인간 동물
|
FI4050034T3
(fi)
|
2016-09-14 |
2024-06-10 |
Teneoone Inc |
Cd3:een sitoutuvia vasta-aineita
|
EP4215548A1
(en)
|
2016-12-21 |
2023-07-26 |
Teneobio, Inc. |
Anti-bcma heavy chain-only antibodies
|
JP2020525408A
(ja)
|
2017-06-09 |
2020-08-27 |
ジェモアブ モノクローナルズ ゲゼルシャフト ミット ベシュレンクテル ハフツングGEMoaB Monoclonals GmbH |
共通キメラ抗原受容体発現免疫細胞のためのターゲティングモジュールならびに癌、感染および自己免疫障害の処置における使用
|
EP3642237A2
(en)
|
2017-06-20 |
2020-04-29 |
Teneobio, Inc. |
Anti-bcma heavy chain-only antibodies
|
JP7240335B2
(ja)
|
2017-06-20 |
2023-03-15 |
テネオワン, インコーポレイテッド |
抗bcma重鎖のみ抗体
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
KR20200049757A
(ko)
|
2017-06-30 |
2020-05-08 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
인간 도메인을 갖는 항-b 세포 성숙화 항원 키메라성 항원 수용체
|
BR112020007002A2
(pt)
|
2017-10-10 |
2020-11-17 |
Sanofi |
anticorpos anti-cd38 e métodos de uso
|
EP3732199A1
(en)
|
2017-12-27 |
2020-11-04 |
TeneoBio, Inc. |
Cd3-delta/epsilon heterodimer specific antibodies
|
SG11202011589WA
(en)
|
2018-05-24 |
2020-12-30 |
Ayala Pharmaceuticals Inc |
Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof
|
CN116769032A
(zh)
|
2018-07-20 |
2023-09-19 |
坦尼奥第二公司 |
与cd19结合的重链抗体
|
BR112021019334A2
(pt)
|
2019-04-05 |
2021-12-07 |
Teneobio Inc |
Anticorpos de cadeia pesada que se ligam ao psma
|
CA3140816A1
(en)
|
2019-06-14 |
2020-12-17 |
Nathan Trinklein |
Multispecific heavy chain antibodies binding to cd22 and cd3
|
CA3176792C
(en)
|
2020-04-29 |
2024-06-18 |
Katherine HARRIS |
Anti-cd3 and anti-bcma bispecific antibodies wth modified heavy chain constant regions
|